1. Home
  2. AVEX vs JANX Comparison

AVEX vs JANX Comparison

Compare AVEX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEVEX Corp. Class A Common Stock

AVEX

AEVEX Corp. Class A Common Stock

N/A

Current Price

$16.45

Market Cap

866.3M

Sector

Industrials

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$16.40

Market Cap

840.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVEX
JANX
Founded
N/A
2017
Country
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
866.3M
840.4M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
AVEX
JANX
Price
$16.45
$16.40
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
$47.00
AVG Volume (30 Days)
2.5M
1.5M
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.07
$12.12
52 Week High
$22.45
$35.34

Technical Indicators

Market Signals
Indicator
AVEX
JANX
Relative Strength Index (RSI) 46.43 66.25
Support Level $15.07 $13.00
Resistance Level $22.45 $16.60
Average True Range (ATR) 1.82 0.72
MACD -0.18 0.22
Stochastic Oscillator 17.91 82.88

Price Performance

Historical Comparison
AVEX
JANX

About AVEX AEVEX Corp. Class A Common Stock

AEVEX Corp is a defense technology company delivering next-generation navigation and autonomy, uncrewed systems, and adaptable mission solutions engineered to need, delivered at speed, and built for the modern battlespace. Its solutions are sold to agencies and organizations within the DoW, SOF, IC, and allied international partners. The group offers products and solutions such as CompassCore, CompassVision, CompassEngage, Precision Strike Systems, Unmanned Surface Vessels, Long Endurance Aircraft, Additive Manufacturing, Full Spectrum Airborne ISR, Aircraft Modification and Testing, and Others.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: